查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750777

靜脈輸液幫浦市場規模、佔有率、趨勢分析報告：依產品、適應症、地區、細分市場預測，2025-2030 年

Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

靜脈輸液幫浦市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球靜脈輸液幫浦市場規模預計到 2030 年將達到 99.8 億美元，預測期內的複合年成長率為 8.5%。

癌症、糖尿病、心血管疾病和呼吸系統疾病等慢性疾病的盛行率日益上升，需要精準的藥物治療和治療管理，推動了對輸液幫浦的需求。

全球人口老化進一步加速了輸液幫浦的普及，尤其是在門診病人和居家照護環境中，以便為需要接受複雜藥物治療的老年患者提供安全且精準的藥物輸送。世界衛生組織 (WHO) 報告稱，2024 年出生時的平均壽命將達到 73.3 歲，比 1995 年增加 8.4 歲。此外，預計到 2030 年，全球 60 歲及以上人口將從 2023 年的 11 億增加到 14 億，這凸顯了對此類技術日益成長的需求。

輸液幫浦技術進步顯著推動了市場需求。智慧型輸液幫浦具備無線連接、電子病歷整合和自動編程功能，可最大限度地減少用藥錯誤，簡化工作流程，進而提高病人安全性和業務效率。

靜脈輸液幫浦市場亮點：

  • 2024 年，定量輸液幫浦佔據了各產品領域最大的市場佔有率。其精確輸送大量液體的有效性對於癌症和糖尿病等慢性疾病的治療以及外科手術至關重要。
  • 預計胰島素輸注幫浦在預測​​期內將以超過9.0%的複合年成長率快速成長。全球糖尿病盛行率不斷上升，主要原因是人口老化、不健康的生活方式以及肥胖率的上升，這推動了胰島素幫浦的需求。
  • 小兒科/新生兒科在疾病適應症領域佔據主導地位，佔 2024 年總收入佔有率的 25.0% 以上。
  • 由於癌症患者數量的增加和癌症治療藥物的快速發展，預計化療領域在預測期內將以最快的複合年成長率成長。
  • 由於先進的醫療基礎設施、日益​​增多的慢性病以及技術進步，北美在靜脈輸液泵市場佔據主導地位。
  • 2024年5月，穆格公司（Moog Inc.）的CURLIN 8,000門診輸液系統獲得FDA 510(k)認證。這款全新的多療法平台旨在提升家庭輸液環境中的易用性和安全性。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章靜脈輸液幫浦市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 靜脈輸液幫浦市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
  • 靜脈輸液幫浦市場：管道分析

第4章靜脈輸液幫浦市場：產品評估與趨勢分析

  • 產品細分儀表板
  • 靜脈輸液幫浦市場：產品差異分析
  • 全球靜脈輸液幫浦市場規模及趨勢分析（依產品，2018-2030）
  • 容積式輸液泵
  • 注射輸液幫浦
  • 胰島素輸注泵
  • 腸內輸液泵
  • 攜帶式輸液泵
  • 病人自控鎮痛輸液泵
  • 植入式輸液泵
  • 其他

第5章靜脈輸液幫浦市場：疾病適應症評估與趨勢分析

  • 疾病適應症細分儀表板
  • 靜脈輸液幫浦市場：疾病適應症變異分析
  • 全球靜脈輸液幫浦市場規模及趨勢分析（依疾病適應症，2018-2030年）
  • 化療
  • 糖尿病
  • 胃腸病學
  • 鎮痛/疼痛管理
  • 小兒科/新生兒科
  • 血液學
  • 其他

6. 靜脈輸液幫浦市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 靜脈輸液幫浦市場各地區概況及要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Baxter
    • B. Braun Medical Inc.
    • Medtronic
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • Cardinal Health
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care, Inc.
    • Terumo Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Moog Inc.
    • IRadimed Corporation
Product Code: GVR-4-68038-560-1

Intravenous Infusion Pumps Market Growth & Trends:

The global intravenous infusion pumps market size is anticipated to reach USD 9.98 billion by 2030 and is anticipated to expand at a CAGR of 8.5% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions, including cancer, diabetes, cardiovascular, and respiratory diseases, necessitates precise medication and therapy administration, thereby driving the demand for infusion pumps.

The global aging population further amplifies the adoption of infusion pumps, particularly in outpatient and home care settings, where they facilitate safe and accurate drug delivery for elderly patients managing complex medication regimens. The World Health Organization reported that life expectancy at birth increased to 73.3 years in 2024, a rise of 8.4 years since 1995. Moreover, the global population aged 60 and older is projected to reach 1.4 billion by 2030, up from 1.1 billion in 2023, highlighting the growing need for such technologies.

Technological advancements in infusion pump capabilities significantly bolster market demand. Smart infusion pumps, featuring wireless connectivity, EHR integration, and automated programming, enhance patient safety and operational efficiency by minimizing medication errors and streamlining workflows

Intravenous Infusion Pumps Report Highlights:

  • Volumetric infusion pumps held the largest market share in the product segment in 2024. Their efficacy in delivering large volumes precisely is vital in managing chronic diseases such as cancer and diabetes and in surgical procedures.
  • Insulin infusion pumps are projected to grow at the fastest CAGR of over 9.0% over the forecast period. The global rise in diabetes prevalence, primarily due to aging populations, unhealthy lifestyles, and increasing obesity rates, has driven insulin pump demand.
  • Pediatrics/neonatology dominated the disease indication segment with over 25.0% of the total revenue share in 2024.
  • The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period, driven by the rising number of cancer cases and rapid development in oncological drugs.
  • North America dominated the intravenous infusion pumps market due to its advanced medical infrastructure, increasing chronic disease prevalence, and technological advancements.
  • In May 2024, Moog Inc. received FDA 510(k) clearance for its CURLIN 8000 Ambulatory Infusion System. This new multi-therapy platform was designed for enhanced usability and safety in home infusion settings.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Indication
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Disease indication outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Intravenous Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Intravenous Infusion Pumps Market: Pipeline Analysis

Chapter 4. Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Intravenous Infusion Pumps Market: Product Movement Analysis
  • 4.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Volumetric Infusion Pumps
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Syringe Infusion Pumps
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Insulin Infusion Pumps
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enteral Infusion Pumps
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Ambulatory Infusion Pumps
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Patient-Controlled Analgesia Infusion Pumps
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Implantable Infusion Pumps
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 5.1. Disease Indication Segment Dashboard
  • 5.2. Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • 5.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Gastroenterology
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Analgesia/Pain Management
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Pediatrics/Neonatology
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Hematology
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Intravenous infusion pumps market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. China
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Baxter
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. B. Braun Medical Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Medtronic
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Micrel Medical Devices SA
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Boston Scientific Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Cardinal Health
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Fresenius Kabi AG
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. ICU Medical, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. F. Hoffmann-La Roche Ltd
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Tandem Diabetes Care, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Terumo Corporation
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Moog Inc.
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. IRadimed Corporation
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 5 North America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 8 U.S. intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 10 Canada intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 12 Mexico intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 14 Europe intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 17 UK intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 19 Germany intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 21 France intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 22 France intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 23 Italy intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 25 Spain intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 27 Denmark intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 29 Sweden intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 31 Norway intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 36 China intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 37 China intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 38 Japan intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 39 Japan intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 40 India intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 41 India intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 42 Australia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 44 South Korea intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 46 Thailand intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 48 Latin America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America laparoscopic ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 51 Latin America percutaneous ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 52 Latin America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 53 Brazil intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 54 Brazil surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 55 Argentina intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 56 Argentina surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
  • Table 57 MEA intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
  • Table 58 MEA intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 59 MEA intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 60 South Africa intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Africa intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 64 UAE intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 65 UAE intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
  • Table 66 Kuwait intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
  • Table 67 Kuwait intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Intravenous infusion pumps market: market outlook
  • Fig. 10 Intravenous infusion pumps competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Intravenous infusion pumps market driver impact
  • Fig. 16 Intravenous infusion pumps market restraint impact
  • Fig. 17 Intravenous infusion pumps market strategic initiatives analysis
  • Fig. 18 Intravenous infusion pumps market: Product movement analysis
  • Fig. 19 Intravenous infusion pumps market: Product outlook and key takeaways
  • Fig. 20 Volumetric infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 21 Syringe infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 22 Insulin infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 23 Enteral infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 24 Ambulatory infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 25 Patient-controlled analgesia infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 26 Implantable infusion pumps estimates and forecast, 2018 - 2030
  • Fig. 27 Others estimates and forecast, 2018 - 2030
  • Fig. 28 Intravenous infusion pumps market: Disease indication movement analysis
  • Fig. 29 Intravenous infusion pumps market: Disease indication outlook and key takeaways
  • Fig. 30 Chemotherapy estimates and forecast, 2018 - 2030
  • Fig. 31 Diabetes estimates and forecast, 2018 - 2030
  • Fig. 32 Gastroenterology estimates and forecast, 2018 - 2030
  • Fig. 33 Analgesia/pain management estimates and forecast, 2018 - 2030
  • Fig. 34 Pediatrics/neonatology estimates and forecast, 2018 - 2030
  • Fig. 35 Hematology estimates and forecast, 2018 - 2030
  • Fig. 36 Others estimates and forecast, 2018 - 2030
  • Fig. 37 Global intravenous infusion pumps market: Regional movement analysis
  • Fig. 38 Global intravenous infusion pumps market: Regional outlook and key takeaways
  • Fig. 39 North America market estimates and forecasts, 2018 - 2030
  • Fig. 40 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 42 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030
  • Fig. 45 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 53 China market estimates and forecasts, 2018 - 2030
  • Fig. 54 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 55 India market estimates and forecasts, 2018 - 2030
  • Fig. 56 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 58 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 62 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 65 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030